Intellia Therapeutics Stock Forecast - Naive Prediction

NTLA Stock  USD 14.30  0.50  3.62%   
The Naive Prediction forecasted value of Intellia Therapeutics on the next trading day is expected to be 13.79 with a mean absolute deviation of 1.18 and the sum of the absolute errors of 72.01. Intellia Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Intellia Therapeutics stock prices and determine the direction of Intellia Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Intellia Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Payables Turnover is expected to grow to 61.30, whereas Inventory Turnover is forecasted to decline to (0.10). . As of November 24, 2024, Common Stock Shares Outstanding is expected to decline to about 50.5 M. The current year's Net Loss is expected to grow to about (405.4 M).

Intellia Therapeutics Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Intellia Therapeutics' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2014-12-31
Previous Quarter
130.8 M
Current Value
120.5 M
Quarterly Volatility
118.8 M
 
Yuan Drop
 
Covid
A naive forecasting model for Intellia Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Intellia Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Intellia Therapeutics Naive Prediction Price Forecast For the 25th of November

Given 90 days horizon, the Naive Prediction forecasted value of Intellia Therapeutics on the next trading day is expected to be 13.79 with a mean absolute deviation of 1.18, mean absolute percentage error of 2.01, and the sum of the absolute errors of 72.01.
Please note that although there have been many attempts to predict Intellia Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Intellia Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Intellia Therapeutics Stock Forecast Pattern

Backtest Intellia TherapeuticsIntellia Therapeutics Price PredictionBuy or Sell Advice 

Intellia Therapeutics Forecasted Value

In the context of forecasting Intellia Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Intellia Therapeutics' downside and upside margins for the forecasting period are 9.45 and 18.14, respectively. We have considered Intellia Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
14.30
13.79
Expected Value
18.14
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Intellia Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Intellia Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.8083
BiasArithmetic mean of the errors None
MADMean absolute deviation1.1804
MAPEMean absolute percentage error0.0651
SAESum of the absolute errors72.0066
This model is not at all useful as a medium-long range forecasting tool of Intellia Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Intellia Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Intellia Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intellia Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
10.1314.4718.81
Details
Intrinsic
Valuation
LowRealHigh
12.8731.2435.58
Details
Bollinger
Band Projection (param)
LowMiddleHigh
13.6614.1314.60
Details
30 Analysts
Consensus
LowTargetHigh
75.7683.2592.41
Details

Other Forecasting Options for Intellia Therapeutics

For every potential investor in Intellia, whether a beginner or expert, Intellia Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Intellia Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Intellia. Basic forecasting techniques help filter out the noise by identifying Intellia Therapeutics' price trends.

Intellia Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intellia Therapeutics stock to make a market-neutral strategy. Peer analysis of Intellia Therapeutics could also be used in its relative valuation, which is a method of valuing Intellia Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Intellia Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Intellia Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Intellia Therapeutics' current price.

Intellia Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Intellia Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Intellia Therapeutics shares will generate the highest return on investment. By undertsting and applying Intellia Therapeutics stock market strength indicators, traders can identify Intellia Therapeutics entry and exit signals to maximize returns.

Intellia Therapeutics Risk Indicators

The analysis of Intellia Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Intellia Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting intellia stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Intellia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intellia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intellia Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intellia Therapeutics Stock:
Check out Historical Fundamental Analysis of Intellia Therapeutics to cross-verify your projections.
For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. If investors know Intellia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intellia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.45)
Revenue Per Share
0.449
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.28)
Return On Equity
(0.52)
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intellia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intellia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intellia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.